ProAir Digihaler in COPD Disease Management: A Real World Study
Conditions: COPD; COPD Exacerbation Acute Interventions: Drug: ProAir Digihaler; Device: Digihaler Sponsors: Pulmonary Research Institute of Southeast Michigan; Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2021 Category: Research Source Type: clinical trials